HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

France Limits Sale Of OTC Analgesics In Response To Covid-19

Executive Summary

France limits OTC sales of paracetamol to one pack per person with no Covid-19 symptoms and two packs for those with pain and/or fever. Online sales of medicines containing paracetamol, ibuprofen and/or aspirin are also now suspended.

You may also be interested in...



COVID-19 Prompts OTC Sales Restrictions Across Europe

Countries across Europe are restricting sales of OTC drugs in response to COVID-19 to maintain supply and counteract stockpiling. The approach varies widely across the region: countries such as Germany and France have introduced strict limits, while others, such as the UK and Ireland, have not ordered official restrictions. HBW Insight presents an analysis of the actions taken by 14 European countries to the upsurge in demand for OTCs.

EU Wholesalers Working ‘Relentlessly’ To Meet Demand For OTCs

HBWI Exclusive: As the coronavirus pandemic worsens across Europe, the region's wholesalers work at full capacity to keep up with demand for OTC products. 

EU Coronavirus Situation 'Evolving Very Rapidly' Says AESGP

In response to the outbreak of the Covid-19 pandemic in Europe, the region's self-care industry is working hard to keep shelves stocked with crucial OTC medicines, food supplements and self-care medical devices, according to the AESGP.

Related Content

Topics

UsernamePublicRestriction

Register

RS149811

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel